Used in the synthesis of glycopeptide-based vaccines and therapeutic agents, particularly in cancer immunotherapy research. This compound serves as a building block for solid-phase peptide synthesis, enabling the incorporation of complex tumor-associated carbohydrate antigens into larger peptide structures. Its protected sugar moieties allow for precise glycosylation patterns that mimic natural epitopes on cancer cells, facilitating the development of immune-targeting molecules. Commonly applied in generating synthetic glycoconjugates for antibody production and immune response studies.